218 related articles for article (PubMed ID: 32506673)
1. Pharmacologic inhibition of transient receptor channel vanilloid 4 attenuates abdominal aortic aneurysm formation.
Shannon AH; Elder CT; Lu G; Su G; Mast A; Salmon MD; Montgomery WG; Spinosa MD; Upchurch GR; Sharma AK
FASEB J; 2020 Jul; 34(7):9787-9801. PubMed ID: 32506673
[TBL] [Abstract][Full Text] [Related]
2. Resolvin D1 decreases abdominal aortic aneurysm formation by inhibiting NETosis in a mouse model.
Spinosa M; Su G; Salmon MD; Lu G; Cullen JM; Fashandi AZ; Hawkins RB; Montgomery W; Meher AK; Conte MS; Sharma AK; Ailawadi G; Upchurch GR
J Vasc Surg; 2018 Dec; 68(6S):93S-103S. PubMed ID: 30470363
[TBL] [Abstract][Full Text] [Related]
3. Resolution of inflammation via RvD1/FPR2 signaling mitigates Nox2 activation and ferroptosis of macrophages in experimental abdominal aortic aneurysms.
Filiberto AC; Ladd Z; Leroy V; Su G; Elder CT; Pruitt EY; Hensley SE; Lu G; Hartman JB; Zarrinpar A; Sharma AK; Upchurch GR
FASEB J; 2022 Nov; 36(11):e22579. PubMed ID: 36183323
[TBL] [Abstract][Full Text] [Related]
4. Experimental abdominal aortic aneurysm formation is mediated by IL-17 and attenuated by mesenchymal stem cell treatment.
Sharma AK; Lu G; Jester A; Johnston WF; Zhao Y; Hajzus VA; Saadatzadeh MR; Su G; Bhamidipati CM; Mehta GS; Kron IL; Laubach VE; Murphy MP; Ailawadi G; Upchurch GR
Circulation; 2012 Sep; 126(11 Suppl 1):S38-45. PubMed ID: 22965992
[TBL] [Abstract][Full Text] [Related]
5. Mesenchymal Stem Cells Attenuate NADPH Oxidase-Dependent High Mobility Group Box 1 Production and Inhibit Abdominal Aortic Aneurysms.
Sharma AK; Salmon MD; Lu G; Su G; Pope NH; Smith JR; Weiss ML; Upchurch GR
Arterioscler Thromb Vasc Biol; 2016 May; 36(5):908-18. PubMed ID: 26988591
[TBL] [Abstract][Full Text] [Related]
6. Genetic and pharmacologic disruption of interleukin-1β signaling inhibits experimental aortic aneurysm formation.
Johnston WF; Salmon M; Su G; Lu G; Stone ML; Zhao Y; Owens GK; Upchurch GR; Ailawadi G
Arterioscler Thromb Vasc Biol; 2013 Feb; 33(2):294-304. PubMed ID: 23288154
[TBL] [Abstract][Full Text] [Related]
7. Pharmacologic inhibition by spironolactone attenuates experimental abdominal aortic aneurysms.
Ladd Z; Su G; Hartman J; Lu G; Hensley S; Upchurch GR; Sharma AK
Front Cardiovasc Med; 2023; 10():1101389. PubMed ID: 36776267
[TBL] [Abstract][Full Text] [Related]
8. Aldehyde dehydrogenase 2 protects against abdominal aortic aneurysm formation by reducing reactive oxygen species, vascular inflammation, and apoptosis of vascular smooth muscle cells.
Tsai SH; Hsu LA; Tsai HY; Yeh YH; Lu CY; Chen PC; Wang JC; Chiu YL; Lin CY; Hsu YJ
FASEB J; 2020 Jul; 34(7):9498-9511. PubMed ID: 32463165
[TBL] [Abstract][Full Text] [Related]
9. Chemokine (C-X-C motif) receptor 4 blockade by AMD3100 inhibits experimental abdominal aortic aneurysm expansion through anti-inflammatory effects.
Michineau S; Franck G; Wagner-Ballon O; Dai J; Allaire E; Gervais M
Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1747-55. PubMed ID: 24876351
[TBL] [Abstract][Full Text] [Related]
10. Transient exposure to elastase induces mouse aortic wall smooth muscle cell production of MCP-1 and RANTES during development of experimental aortic aneurysm.
Colonnello JS; Hance KA; Shames ML; Wyble CW; Ziporin SJ; Leidenfrost JE; Ennis TL; Upchurch GR; Thompson RW
J Vasc Surg; 2003 Jul; 38(1):138-46. PubMed ID: 12844103
[TBL] [Abstract][Full Text] [Related]
11. CD95-ligand contributes to abdominal aortic aneurysm progression by modulating inflammation.
Liu Z; Fitzgerald M; Meisinger T; Batra R; Suh M; Greene H; Penrice AJ; Sun L; Baxter BT; Xiong W
Cardiovasc Res; 2019 Mar; 115(4):807-818. PubMed ID: 30428004
[TBL] [Abstract][Full Text] [Related]
12. Inhibition or deletion of angiotensin II type 1 receptor suppresses elastase-induced experimental abdominal aortic aneurysms.
Xuan H; Xu B; Wang W; Tanaka H; Fujimura N; Miyata M; Michie SA; Dalman RL
J Vasc Surg; 2018 Feb; 67(2):573-584.e2. PubMed ID: 28434702
[TBL] [Abstract][Full Text] [Related]
13. Disruption of TGF-β signaling in smooth muscle cell prevents elastase-induced abdominal aortic aneurysm.
Gao F; Chambon P; Offermanns S; Tellides G; Kong W; Zhang X; Li W
Biochem Biophys Res Commun; 2014 Nov; 454(1):137-43. PubMed ID: 25450370
[TBL] [Abstract][Full Text] [Related]
14. Fcγ receptor activation mediates vascular inflammation and abdominal aortic aneurysm development.
Lopez-Sanz L; Bernal S; Jimenez-Castilla L; Prieto I; La Manna S; Gomez-Lopez S; Blanco-Colio LM; Egido J; Martin-Ventura JL; Gomez-Guerrero C
Clin Transl Med; 2021 Jul; 11(7):e463. PubMed ID: 34323424
[TBL] [Abstract][Full Text] [Related]
15. A novel STAT3 inhibitor attenuates angiotensin II-induced abdominal aortic aneurysm progression in mice through modulating vascular inflammation and autophagy.
Wu QY; Cheng Z; Zhou YZ; Zhao Y; Li JM; Zhou XM; Peng HL; Zhang GS; Liao XB; Fu XM
Cell Death Dis; 2020 Feb; 11(2):131. PubMed ID: 32071300
[TBL] [Abstract][Full Text] [Related]
16. Excessive EP4 Signaling in Smooth Muscle Cells Induces Abdominal Aortic Aneurysm by Amplifying Inflammation.
Hiromi T; Yokoyama U; Kurotaki D; Mamun A; Ishiwata R; Ichikawa Y; Nishihara H; Umemura M; Fujita T; Yasuda S; Minami T; Goda M; Uchida K; Suzuki S; Takeuchi I; Masuda M; Breyer RM; Tamura T; Ishikawa Y
Arterioscler Thromb Vasc Biol; 2020 Jun; 40(6):1559-1573. PubMed ID: 32321307
[TBL] [Abstract][Full Text] [Related]
17. Inhibiting the Th17/IL-17A-related inflammatory responses with digoxin confers protection against experimental abdominal aortic aneurysm.
Wei Z; Wang Y; Zhang K; Liao Y; Ye P; Wu J; Wang Y; Li F; Yao Y; Zhou Y; Liu J
Arterioscler Thromb Vasc Biol; 2014 Nov; 34(11):2429-38. PubMed ID: 25234817
[TBL] [Abstract][Full Text] [Related]
18. D-series resolvins inhibit murine abdominal aortic aneurysm formation and increase M2 macrophage polarization.
Pope NH; Salmon M; Davis JP; Chatterjee A; Su G; Conte MS; Ailawadi G; Upchurch GR
FASEB J; 2016 Dec; 30(12):4192-4201. PubMed ID: 27619672
[TBL] [Abstract][Full Text] [Related]
19. Thrombospondin-1 (TSP1) contributes to the development of vascular inflammation by regulating monocytic cell motility in mouse models of abdominal aortic aneurysm.
Liu Z; Morgan S; Ren J; Wang Q; Annis DS; Mosher DF; Zhang J; Sorenson CM; Sheibani N; Liu B
Circ Res; 2015 Jul; 117(2):129-41. PubMed ID: 25940549
[TBL] [Abstract][Full Text] [Related]
20. Pharmacologic blockade and genetic deletion of androgen receptor attenuates aortic aneurysm formation.
Davis JP; Salmon M; Pope NH; Lu G; Su G; Meher A; Ailawadi G; Upchurch GR
J Vasc Surg; 2016 Jun; 63(6):1602-1612.e2. PubMed ID: 26817611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
